Aktienanalyse zu 111 Inc (YI)

$3.460

0.000 (0.00%)Zum Schluss

Loading chart…

High: 3.460
Open: 3.600
VWAP: —
Vol: 0.00
Mkt Cap: 92.95M
Low: 3.460
Amount: 0.00
EV/EBITDA, TTM: 0.00

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.

corporate.111.com.cn

Analyst Ratings (1)

Buy

1 Buy

0 Hold

0 Sell

Current: 3.46

Tief

—

Durchschnitt

—

Hoch

—

See All Ratings

Bewertungskennzahlen

The current forward P/E ratio for 111 Inc (YI) is 0.00, compared to its 5-year average forward P/E of 16.13.

Forward P/E

Fair

5Y Average P/E

16.13

Current P/E

0.00

Überbewertet

65.66

Unterbewertet

-33.41

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

2.95

Current EV/EBITDA

0.00

Überbewertet

26.77

Unterbewertet

-20.88

Forward P/S

Fair

5Y Average P/S

0.07

Current P/S

0.04

Überbewertet

0.11

Unterbewertet

0.03

Event-Zeitleiste

2026-01-30 (ET)